Gilead

News

How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy

July 22, 2023

In 2004, Gilead Sciences determined to prevent pursuing a new H.I.V. drug. The public explanation used to be that it wasn’t sufficiently other from...

Money

Jury rules for Gilead in case involving PrEP HIV treatment

May 9, 2023

Comment in this taleCommentA federal jury rejected claims by means of the U.S. executive that Gilead Sciences infringed on its patents for an...

Money

Trial imminent for U.S. lawsuit against Gilead over HIV treatment

May 2, 2023

Comment in this taleCommentThe United States’ brawl with Gilead Sciences over possession of an anti-HIV routine will move to trial Tuesday, marking one...